Image

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.

Description

The complete revascularization versus culprit lesion only PCI in NSTEMI (COMPLETE-NSTEMI) trial aims to investigate whether multivessel complete PCI is superior over culprit-lesion only PCI in patients with NSTEMI and multivessel coronary artery disease.

Eligibility

Inclusion Criteria:

  • NSTEMI as suggested by high-sensitivity troponin algorithms
  • Multivessel coronary artery disease
  • Identifiable culprit lesion
  • Informed consent

Exclusion Criteria:

  • Age <18 years
  • Cardiogenic shock
  • Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
  • Contraindication for coronary revascularization
  • Prior coronary artery bypass graft
  • Indication for coronary artery bypass graft surgery
  • Co-morbidity with life expectancy less than 6 months
  • Type 2 myocardial infarction

Study details
    Non-ST-elevation Myocardial Infarction
    Multivessel Coronary Artery Disease

NCT05786131

Leipzig Heart Science gGmbH

21 March 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.